NCT06278766 A Study to Assess the Mass Balance of [14C] ABBV-552 in Healthy Male Participants Following Single Oral Dose Administration Status COMPLETED Phase PHASE1
NCT06257875 A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06256367 Observational Study of Oral Cariprazine Capsules to Assess Change in Disease Activity in Adult Participants With Bipolar I Disorder Status COMPLETED Phase N/A
NCT06247540 Venetoclax, Rituximab and Nivolumab in Combination for the Treatment of Richter's Transformation Arising From Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Status WITHDRAWN Phase PHASE2
NCT06247319 Study to Evaluate the Effectiveness of Risankizumab in Participants With a Recent Diagnosis of Moderate Plaque Psoriasis in a Real-life Setting in Greece Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06241313 Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06236438 Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Status RECRUITING Phase PHASE2/PHASE3
NCT06223516 Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06218251 A Study to Evaluate Participant Satisfaction and Natural Outcomes Following Administration of BOTOX Cosmetic Injections in Adult Participants for Treatment of Upper Facial Lines Status COMPLETED Phase PHASE4
NCT06191744 Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma Status RECRUITING Phase PHASE3
NCT06174688 A Study to Assess the Adverse Events and Effectiveness of BOTOX Injections for the Treatment of Moderate to Severe Forehead Lines in Chinese Adult Participants Status COMPLETED Phase PHASE3
NCT06158958 A Study to Assess the Safety, Pharmacokinetics, and Efficacy of Intravenous (IV) ABBV-303, as Monotherapy and in Combination With IV Infused Budigalimab (ABBV-181), in Adults With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT06158854 A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion Status RECRUITING Phase PHASE1/PHASE2
NCT06158841 Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma Status RECRUITING Phase PHASE3
NCT06158100 Venetoclax in Combination With Azacitidine (VEN/AZA) Followed by Donor Lymphocyte Infusion (DLI) for Patients With Very High-Risk Acute Myeloid Leukemia (AML) Undergoing Allogeneic Hematopoietic Cell Transplant (HCT) Status SUSPENDED Phase PHASE1
NCT06151561 Study of AGN-151586 in Japanese Participants With Moderate to Severe Glabellar Lines Status COMPLETED Phase PHASE1
NCT06151535 A Study to Evaluate the Safety and Effectiveness of ELAPR002f Injectable Gel for the Improvement of Skin Quality in Adult Participants Status COMPLETED Phase PHASE2
NCT06150729 Study of Intramuscular Injections of OnabotulinumtoxinA to Assess Change in Disease Activity in Pediatric Participants With Spasticity Associated With Cerebral Palsy Status COMPLETED Phase N/A
NCT06148181 A Study to Evaluate Adverse Events and How Single Ascending Doses of ABBV-141 Move Through the Body of Healthy Adult Western and Asian Participants Status COMPLETED Phase PHASE1
NCT06145607 A Phase 1 Study Assessing the Effect of Food on the Pharmacokinetics of ABBV- CLS-7262 Status COMPLETED Phase PHASE1